NCT00605605View on ClinicalTrials.gov

Vascular Endothelial Protection Effects of Dextromethorphan

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
AtherosclerosisSmokingInflammation
Interventions
DRUG

Dextromethorphan

120 mg/day, single once daily dose taken after breakfast by oral route

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT00605605 - Vascular Endothelial Protection Effects of Dextromethorphan | Biotech Hunter | Biotech Hunter